Table of contents

Extended reports

• Local and systemic glucocorticoid metabolism in inflammatory arthritis (17 April, 2008)

  R Hardy, E H Rabbitt, A Filer, P Emery, M Hewison, P M Stewart, N J Gittoes, C D Buckley, K Raza, M S Cooper
• Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis (6 December, 2007)

  M L Ferrándiz, N Maicas, I Garcia-Arnandis, M C Terencio, R Motterlini, I Devesa, L A B Joosten, W B van den Berg, M J Alcaraz
• Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis (4 December, 2007)

  D van der Heijde, A L Pangan, M H Schiff, J Braun, M Borofsky, J Torre, J C Davis, R L Wong, H Kupper, E Collantes, for the ATLAS Study Group
• Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases (30 November, 2007)

  C P Denton, J E Pope, H-H Peter, A Gabrielli, A Boonstra, F H J van den Hoogen, G Riemekasten, S De Vita, A Morganti, M Dölberg, O Berkani, L Guillevin, (on behalf of the TRacleer Use in PAH associated with Scleroderma and Connective Tissue Diseases (TRUST) Investigators)
• The effectiveness and medication costs of three anti-tumour necrosis factor α agents in the treatment of rheumatoid arthritis from prospective clinical practice data (3 January, 2008)

  W Kievit, E M Adang, J Fransen, H H Kuper, M A F J van de Laar, T L Jansen, C M A De Gendt, D-J R A M De Rooij, H L M Brus, P C M Van Oijen, P C L M Van Riel
• Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells (4 December, 2007)

  L Salazar, O Aravena, P Abello, A Escobar, J Contreras-Levicoy, N Rojas-Colonelli, D Catalán, A Aguirre, R Zúñiga, B Pesce, C González, R Cepeda, M Cuchacovich, M C Molina, F Salazar-Onfray, M Delgado, R E Toes, J C Aguillón
• COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker (7 December, 2007)

  R Hesselstrand, A Kassner, D Heinegård, T Saxne
• High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study (7 December, 2007)

  P Szulc, A Montella, P D Delmas
• Association between leptin, body composition, sex and knee cartilage morphology in older adults: the Tasmanian older adult cohort (TASOAC) study (3 January, 2008)

  C Ding, V Parameswaran, F Cicuttini, J Burgess, G Zhai, S Quinn, G Jones
• Corticosteroid injections effective for trigger finger in adults in general practice: a double-blinded randomised placebo controlled trial (7 January, 2008)

  C Peters-Veluthamaningal, J C Winters, K H Groenier, B Meyboom-de Jong
• Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial (18 January, 2008)

  D van der Heijde, R Landewé, R van Vollenhoven, S Fatenejad, L Klareskog
• Clinical features and risk factors of postsurgical gout (12 November, 2007)

  E H Kang, E Y Lee, Y J Lee, Y W Song, E B Lee
• MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis (15 November, 2007)

  M Rudwaleit, S Schwarzlose, E S Hilgert, J Listing, J Braun, J Sieper
• Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case–control study (6 December, 2007)

  B Rozman, S Čučnik, S Sodin-Semrl, L Czirják, C Varjú, O Distler, D Huscher, M Aringer, G Steiner, M Matucci-Cerinić, S Guiducci, B Stamenković, A Stanković, T Kveder
• The FCRL3 −169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases

  (7 December, 2007)

  M C Eike, G B N Nordang, T H Karlsen, K M Boberg, M H Vatn on behalf of the IBSEN study group, K Dahl-Jørgensen, K S Rønningen, G Joner, B Flatø, A Bergquist, E Thorsby, Ø Førre, T K Kvien, D E Undlien, B A Lie
• Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment (7 January, 2008)

  S Stojanov, C Dejaco, P Lohse, K Huss, C Duftner, B H Belohradsky, M Herold, M Schirmer
• Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis (6 December, 2007)

  H Yamada, Y Nakashima, K Okazaki, T Mawatari, J-I Fukushi, N Kaibara, A Hori, Y Iwamoto, Y Yoshikai
• Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis (6 December, 2007)

  A-M Sims, A E Timms, J Bruges-Armas, R Burgos-Vargas, C-T Chou, T Doan, A Dowling, R N Fialho, P Gergely, D D Gladman, R Inman, M Kauppi, K Kaarela, K Laiho, W Maksymowych, J J Pointon, P Rahman, J D Reveille, R Sorrentino, J Tuomilehto, G Vargas-Alarcon, B P Wordsworth, H Xu, M A Brown, on behalf of the International Genetics of Ankylosing Spondylitis
• Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans (4 January, 2008)

  J A Singh, V Strand
• Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma (28 December, 2007)

  M C Vonk, C E van Die, M M Snoeren, K J Bhansing, P L C M van Riel, J Fransen, F H J van den Hoogen
• Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H) (29 November, 2007)

  M Walsh, A Chaudhry, D Jayne
• The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to, or severity of, rheumatoid arthritis (7 January, 2008)

  F J Sheedy, I Marinou, L A J O’Neill, A G Wilson
• Early and long-lasting protection from arthritis in tumour necrosis factor α (TNFα) transgenic mice vaccinated against TNFα (27 November, 2007)

  L Delavallée, H Le Buanec, N Bessis, E Assier, A Denys, B Bizzini, D Zagury, M-C Boissier